UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia · Neutropenia · Anemia · Thrombocytopenia · Infections · Bleeding

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Wuhan Union Hospital, Wuhan, Hubei, China

Study leads

Qiubai Li, Professor
Principal Investigator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

National Longitudinal Cohort of Hematological Diseases

Multiple Myeloma · Acute Myeloid Leukemia · Hemophilia

Abroad (travel likely)Recruiting

Tianjin, China

Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML)

Abroad (travel likely)RecruitingPHASE1

Nanchang, China · Nanchang, China

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia · Recurrent Adult Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States

Venetoclax to Augment Epigenetic Modification and Chemotherapy

Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States